Abivax SA Financials
| ABVX Stock | EUR 6.20 0.42 7.27% |
Abivax |
Understanding current and past Abivax SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abivax SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Abivax SA's assets may result in an increase in income on the income statement.
Please note, the presentation of Abivax SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abivax SA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Abivax SA's management manipulating its earnings.
Abivax SA Stock Summary
Abivax SA competes with Gensight Biologics, Innate Pharma, Poxel SA, and Nanobiotix. ABIVAX Socit Anonyme, a biotechnology company, develops, markets, and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases in Asia and Latin America. The company was incorporated in 2013 and is headquartered in Paris, France. ABIVAX is traded on Paris Stock Exchange in France.| Foreign Associate | USA |
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0012333284 |
| Business Address | 5, rue de |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.abivax.com |
| Phone | 33 1 53 83 08 41 |
| Currency | EUR - Euro |
You should never invest in Abivax SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Abivax Stock, because this is throwing your money away. Analyzing the key information contained in Abivax SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Abivax SA Key Financial Ratios
Abivax SA's financial ratios allow both analysts and investors to convert raw data from Abivax SA's financial statements into concise, actionable information that can be used to evaluate the performance of Abivax SA over time and compare it to other companies across industries.| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Target Price | 38.0 | |||
| Number Of Employees | 24 | |||
| Beta | 1.26 |
Abivax Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abivax SA's current stock value. Our valuation model uses many indicators to compare Abivax SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abivax SA competition to find correlations between indicators driving Abivax SA's intrinsic value. More Info.Abivax SA is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Abivax SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Abivax SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Abivax SA Systematic Risk
Abivax SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abivax SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Abivax SA correlated with the market. If Beta is less than 0 Abivax SA generally moves in the opposite direction as compared to the market. If Abivax SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abivax SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abivax SA is generally in the same direction as the market. If Beta > 1 Abivax SA moves generally in the same direction as, but more than the movement of the benchmark.
Abivax SA March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Abivax SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abivax SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abivax SA based on widely used predictive technical indicators. In general, we focus on analyzing Abivax Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abivax SA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 27.63 | |||
| Value At Risk | (5.93) | |||
| Potential Upside | 7.69 |
Complementary Tools for Abivax Stock analysis
When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |